Overview

Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of triptorelin 11.25 mg pamoate in the delay of premature onset of puberty in girls less than 9 years and boys less than 10 years. This is measured by assessing the proportion of children who have a suppressed Luteinizing Hormone (LH) response to Gonadotropin Releasing Hormone (GnRH) test performed 3 months after injection with triptorelin 11.25 mg.
Phase:
Phase 3
Details
Lead Sponsor:
Ipsen
Treatments:
Triptorelin Pamoate